CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 130 filers reported holding CABALETTA BIO INC in Q4 2023. The put-call ratio across all filers is 1.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $308 | -63.1% | 41,239 | -15.8% | 0.00% | – |
| Q1 2024 | $834 | -71.5% | 48,968 | -62.1% | 0.00% | -100.0% |
| Q4 2023 | $2,930 | +197.8% | 129,072 | +99.8% | 0.00% | 0.0% |
| Q3 2023 | $984 | +1413.8% | 64,586 | +1167.4% | 0.00% | – |
| Q2 2023 | $65 | -88.3% | 5,096 | -92.4% | 0.00% | – |
| Q1 2023 | $555 | +1360.5% | 67,198 | +1520.8% | 0.00% | – |
| Q4 2022 | $38 | -96.2% | 4,146 | +239.6% | 0.00% | – |
| Q3 2022 | $1,000 | -93.8% | 1,221 | -91.9% | 0.00% | – |
| Q2 2022 | $16,000 | -50.0% | 15,163 | -3.5% | 0.00% | – |
| Q1 2022 | $32,000 | – | 15,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,825,976 | $26,140,278 | 22.61% |
| VR Adviser, LLC | 1,895,285 | $17,531,386 | 2.95% |
| CAXTON CORP | 84,728 | $783,735 | 2.00% |
| COMMODORE CAPITAL LP | 1,010,359 | $9,346 | 1.41% |
| BOONE CAPITAL MANAGEMENT LLC | 266,882 | $2,468,659 | 1.27% |
| Cormorant Asset Management, LP | 1,971,739 | $18,239 | 1.22% |
| TCG Crossover Management, LLC | 486,795 | $4,502,854 | 0.80% |
| Boxer Capital, LLC | 540,000 | $4,995,000 | 0.26% |
| Kynam Capital Management, LP | 165,486 | $1,530,746 | 0.24% |
| Eversept Partners, LP | 282,874 | $2,616,585 | 0.23% |